Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.83 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.83 |
| ▸ | CPT2 | P23786 | 1/20 | 0.83 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27542041 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL12451279 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL3623870 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL1873452 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL742996 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL20184209 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL5878804 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL22748728 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| SCHEMBL22748689 | 1.00 | TDP1 (0.83) | TDP1FFAR1CPT2GPR84PPARG | |
| Hydrochloric Acid SCHEMBL8110283 | 0.98 | TDP1 (0.79) | TDP1FFAR1CPT2GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11796725-B2 | Metal oxide microparticles, method for producing same, dispersion for forming infrared-shielding film, method for producing same, method for forming infrared-shielding film, and base material having infrared-shielding film | MITSUBISHI MATERIALS CORPORATION (JP) | 2023-10-24 | — | — | US | claimed |
| EP-2279741-A2 | Caprolactams and their use as anti-inflammatory agents | Cambridge Enterprise Ltd. (GB) | 2011-02-02 | — | — | EP | claimed |
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2008-09-18 | — | — | US | claimed |
| EP-1691814-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-08-23 | — | — | EP | claimed |
| WO-2005053702-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2005-06-16 | — | — | WO | claimed |
| US-11796725-B2 | Metal oxide microparticles, method for producing same, dispersion for forming infrared-shielding film, method for producing same, method for forming infrared-shielding film, and base material having infrared-shielding film | MITSUBISHI MATERIALS CORPORATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20210220328-A1 | PYRROLE DERIVATIVES AS ACC INHIBITORS | ALMIRALL SA (ES) | 2021-07-22 | — | — | US | disclosed |
| US-20210191016-A1 | METAL OXIDE MICROPARTICLES, METHOD FOR PRODUCING SAME, DISPERSION FOR FORMING INFRARED-SHIELDING FILM, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING SAME, METHOD FOR FORMING INFRARED-SHIELDING FILM, AND BASE MATERIAL HAVING INFRARED-SHIELDING FILM | MITSUBISHI MATERIALS CORPORATION (JP) | 2021-06-24 | — | — | US | disclosed |
| EP-3770119-A1 | METAL OXIDE MICROPARTICLES, METHOD FOR PRODUCING SAME, DISPERSION FOR FORMING INFRARED-SHIELDING FILM, METHOD FOR PRODUCING SAME, METHOD FOR FORMING INFRARED-SHIELDING FILM, AND BASE MATERIAL HAVING INFRARED-SHIELDING FILM | Mitsubishi Materials Corporation (JP) | 2021-01-27 | — | — | EP | disclosed |
| CN-111886230-A | Pyrrole derivatives as ACC inhibitors | 阿尔米雷尔有限公司 | 2020-11-03 | — | — | CN | disclosed |
| EP-3724182-A1 | PYRROLE DERIVATIVES AS ACC INHIBITORS | Almirall S.A. (ES) | 2020-10-21 | — | — | EP | disclosed |
| WO-2019115405-A1 | PYRROLE DERIVATIVES AS ACC INHIBITORS | ALMIRALL, S.A. (ES) | 2019-06-20 | — | — | WO | disclosed |
| CN-103393691-A | Anti-inflammatory agents | UNIV CAMBRIDGE TECH | 2013-11-20 | — | — | CN | disclosed |
| EP-1691814-B9 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTPR LTD (GB) | 2013-02-20 | — | — | EP | disclosed |
| EP-1691814-B1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTPR LTD (GB) | 2012-07-25 | — | — | EP | disclosed |
| EP-2279741-A2 | Caprolactams and their use as anti-inflammatory agents | Cambridge Enterprise Ltd. (GB) | 2011-02-02 | — | — | EP | disclosed |
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2008-09-18 | — | — | US | disclosed |
| CN-1897953-A | Anti-inflammatory agents | UNIV CAMBRIDGE TECH (GB) | 2007-01-17 | — | — | CN | disclosed |
| EP-1691814-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005053702-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2005-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | SMURF1, SMURF2, PSEN1 | TDP1 1627/4885FFAR1 177/4885CPT2 292/4885 |
| US-20210220328-A1 | PYRROLE DERIVATIVES AS ACC INHIBITORS | ACACA, ACACB, PCCA | TDP1 3503/4885FFAR1 3053/4885CPT2 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.